GLP-1 medications have dramatically increased in use by patients with and without type 2 diabetes in the past year, yet little real-world data exist to compare the effectiveness of two of the most common medications, semaglutide and tirzepatide, said Tricia Rodriguez, PhD, MPH principal applied scientist, Truveta Research, and lead author on the paper
The gastrointestinal effects result from tirzepatide's action on GLP-1 receptors, which slow gastric emptying and affect gut motility
This makes it uniquely effective for: Visceral fat reduction (glucagon is specifically active on abdominal fat stores) Resting metabolic rate increase (glucagon is thermogenic it raises your metabolic baseline) Food noise suppression (GLP-1 component dampens reward-driven eating) Satiety signaling (GIP + GLP-1 extend fullness after meals) Because of this third mechanism, the clinical trial results for Retatrutide are notably better than other approved GLP-1s for body weight reduction
By balancing serotonin levels, sertraline can help reduce the frequency and severity of anxiety symptoms, making daily activities more manageable for individuals with these conditions
